Refine
Document Type
- Article (5)
- Doctoral Thesis (1)
Language
- English (6)
Has Fulltext
- yes (6)
Is part of the Bibliography
- no (6)
Keywords
- antibody (6) (remove)
Institute
- Institut für Pathologie (3)
- Abteilung für Mikrobiologie und Molekularbiologie (1)
- Institut für Botanik und Landschaftsökologie & Botanischer Garten (1)
- Institut für Immunologie u. Transfusionsmedizin - Abteilung Immunologie (1)
- Interfakultäres Institut für Genetik und Funktionelle Genomforschung (UMG) (1)
Publisher
- MDPI (3)
- Frontiers Media S.A. (2)
Life-threatening toxic shock syndrome is often caused by the superantigen toxic shock syndrome toxin-1 (TSST-1) produced by Staphylococcus aureus. A well-known risk factor is the lack of neutralizing antibodies. To identify determinants of the anti-TSST-1 antibody response, we examined 976 participants of the German population-based epidemiological Study of Health in Pomerania (SHIP-TREND-0). We measured anti-TSST-1 antibody levels, analyzed the colonization with TSST-1-encoding S. aureus strains, and performed a genome-wide association analysis of genetic risk factors. TSST-1-specific serum IgG levels varied over a range of 4.2 logs and were elevated by a factor of 12.3 upon nasal colonization with TSST-1-encoding S. aureus. Moreover, the anti-TSST-1 antibody levels were strongly associated with HLA class II gene loci. HLA-DRB1*03:01 and HLA-DQB1*02:01 were positively, and HLA-DRB1*01:01 as well as HLA-DQB1*05:01 negatively associated with the anti-TSST-1 antibody levels. Thus, both toxin exposure and HLA alleles affect the human antibody response to TSST-1.
In addition to the classical oestrogen receptors, ERα and ERβ, a G protein-coupled oestrogen receptor (GPER) has been identified that primarily mediates the rapid, non-genomic signalling of oestrogens. Data on GPER expression at the protein level are contradictory; therefore, the present study was conducted to re-evaluate GPER expression by immunohistochemistry to obtain broad GPER expression profiles in human non-neoplastic and neoplastic tissues, especially those not investigated in this respect so far. We developed and thoroughly characterised a novel rabbit monoclonal anti-human GPER antibody, 20H15L21, using Western blot analyses and immunocytochemistry. The antibody was then applied to a large series of formalin-fixed, paraffin-embedded human tissue samples. In normal tissue, GPER was identified in distinct cell populations of the cortex and the anterior pituitary; islets and pancreatic ducts; fundic glands of the stomach; the epithelium of the duodenum and gallbladder; hepatocytes; proximal tubules of the kidney; the adrenal medulla; and syncytiotrophoblasts and decidua cells of the placenta. GPER was also expressed in hepatocellular, pancreatic, renal, and endometrial cancers, pancreatic neuroendocrine tumours, and pheochromocytomas. The novel antibody 20H15L21 will serve as a valuable tool for basic research and the identification of GPER-expressing tumours during histopathological examinations.
FAM159B is a so-called adaptor protein. These proteins are essential components in numerous cell signalling pathways. However, little is known regarding FAM159B expression in normal and neoplastic human tissues. The commercially available rabbit polyclonal anti-human FAM159B antibody HPA011778 was initially characterised for its specificity using Western blot analyses and immunocytochemistry and then applied to a large series of formalin-fixed, paraffin-embedded normal and neoplastic human tissue samples. Confirmation of FAM159B’s predicted size and antibody specificity was achieved in BON-1 cells, a neuroendocrine tumour cell line endogenously expressing FAM159B, using targeted siRNA. Immunocytochemical experiments additionally revealed cytoplasmic expression of the adaptor protein. Immunohistochemical staining detected FAM159B expression in neuronal and neuroendocrine tissues such as the cortex, the trigeminal ganglia, dorsal root and intestinal ganglia, the pancreatic islets and the neuroendocrine cells of the bronchopulmonary and gastrointestinal tract, but also in the syncytiotrophoblasts of the placenta. FAM159B was also expressed in many of the 28 tumour entities investigated, with high levels in medullary and anaplastic thyroid carcinomas, parathyroid adenomas, lung and ovarian carcinomas, lymphomas and neuroendocrine tumours of different origins. The antibody HPA011778 can act as a useful tool for basic research and identifying FAM159B expression in tissue samples.
GPR68 (OGR1) belongs to the proton-sensing G protein-coupled receptors that are involved
in cellular adaptations to pH changes during tumour development. Although expression of GPR68
has been described in many tumour cell lines, little is known about its presence in human tumour
entities. We characterised the novel rabbit monoclonal anti-human GPR68 antibody 16H23L16
using various cell lines and tissue specimens. The antibody was then applied to a large series of
formalin-fixed, paraffin-embedded normal and neoplastic human tissue samples. Antibody specificity
was demonstrated in a Western blot analysis of GPR68-expressing cells using specific siRNAs.
Immunocytochemical experiments revealed pH-dependent changes in subcellular localisation of the
receptor and internalisation after stimulation with lorazepam. In normal tissue, GPR68 was present in
glucagon-producing islet cells, neuroendocrine cells of the intestinal tract, gastric glands, granulocytes,
macrophages, muscle layers of arteries and arterioles, and capillaries. GPR68 was also expressed
in neuroendocrine tumours, where it may be a positive prognostic factor, in pheochromocytomas,
cervical adenocarcinomas, and endometrial cancer, as well as in paragangliomas, medullary thyroid
carcinomas, gastrointestinal stromal tumours, and pancreatic adenocarcinomas. Often, tumour
capillaries were also strongly GPR68-positive. The novel antibody 16H23L16 will be a valuable tool for
basic research and for identifying GPR68-expressing tumours during histopathological examinations.
Whether mice are an appropriate model for S. aureus infection and vaccination studies is a matter of debate, because they are not considered as natural hosts of S. aureus. We previously identified a mouse-adapted S. aureus strain, which caused infections in laboratory mice. This raised the question whether laboratory mice are commonly colonized with S. aureus and whether this might impact on infection experiments. Publicly available health reports from commercial vendors revealed that S. aureus colonization is rather frequent, with rates as high as 21% among specific-pathogen-free mice. In animal facilities, S. aureus was readily transmitted from parents to offspring, which became persistently colonized. Among 99 murine S. aureus isolates from Charles River Laboratories half belonged to the lineage CC88 (54.5%), followed by CC15, CC5, CC188, and CC8. A comparison of human and murine S. aureus isolates revealed features of host adaptation. In detail, murine strains lacked hlb-converting phages and superantigen-encoding mobile genetic elements, and were frequently ampicillin-sensitive. Moreover, murine CC88 isolates coagulated mouse plasma faster than human CC88 isolates. Importantly, S. aureus colonization clearly primed the murine immune system, inducing a systemic IgG response specific for numerous S. aureus proteins, including several vaccine candidates. Phospholipase C emerged as a promising test antigen for monitoring S. aureus colonization in laboratory mice. In conclusion, laboratory mice are natural hosts of S. aureus and therefore, could provide better infection models than previously assumed. Pre-exposure to the bacteria is a possible confounder in S. aureus infection and vaccination studies and should be monitored.
The immune system of all vertebrates primarily is responsible to maintain the organisms homeostasis by either eliminating neoplastic or altered body cells and to protect against foreign invaders (viruses, bacteria, fungi, parasites) (Murphy 2012). It is a highly regulated network of innate and adaptive mechanisms between humoral factors and leukocytes. The successful elimination or protection is crucially based on differentiation of self from non-self. Pathogens and altered body cells are recognized by different receptor complexes on immune cells. Expressed pathogen- or danger-associated molecular patterns (PAMPs or DAMPs, respectively) are bound by pattern recognition receptors (PRR) (Takeuchi and Akira 2010). Missing major histocompatibility (MHC) class I molecules or non-self (e.g. allogeneic or xenogeneic cells) MHC are recognized by natural killer cell receptors (Fischer, Koppang and Nakanishi 2013, Raulet 2006). Foreign non-self peptides are presented through MHC class I (intracellular) or through MHC class II (extracellular) to B- cell or T cell receptor complexes. This initial activation is regulated by humoral factors or cellular interactions (receptor-ligand interactions) resulting in the activation, proliferation and effector function within an immune response. Some of the cellular receptors are permanently expressed on all leukocytes on a high level (MHC class I), whereas others only are expressed during certain developmental or activation stages or on certain leukocyte populations (monocytes, granulocytes, NK cells, lymphocytes) (Murphy 2012, Biosciences 2010). For different mammals (man, mouse, rat, but also swine, cattle, dog), a system of characterized leukocyte surface molecules primarily based on the recognition of these molecules by specific monoclonal antibodies (mabs) was summarized at international workshops as clusters of differentiation (CD) (Cobbold and Metcalfe 1994, Hopkins, Ross and Dutia 1993, Haverson et al. 2001, Mason et al. 2001). Using these mabs, it is not only possible to characterize the developmental and functional stage of different leukocyte subpopulations but also to define the interactions between these populations. For bony fish, such a system does not exist. Only a limited number of mabs against leukocyte surface molecules is available and most of them are strongly specific for species (Köllner et al. 2004, Köllner et al. 2001, Zhang et al. 2010, Ramirez-Gomez et al. 2012, Wen et al. 2011, DeLuca, Wilson and Warr 1983, Toda et al. 2011, Toda et al. 2009, Takizawa et al. 2011a, Hetland et al. 2010, Araki et al. 2008). The goal of this PhD work, therefore, was to develop monoclonal antibodies against surface markers of rainbow trout (Oncorhynchus mykiss) T cell population (chapter 2). The lymphocytes are characterized by the expression of a T cell receptor complex composed of TCR chains (α and β) and CD3 chains (α, β, γ, δ, ε and ζ). Cytotoxic T lymphocytes (CTLs) binds to MHC class I bound peptide on the infected host cell using their T cell receptor (TCR) and its co-receptor CD8 resulting in specific killing. Th cells recognize peptides through their T cell receptor (TCR) and their co-receptor CD4 after extracellular antigens uptake, processing and presentation via MHC class II by professional antigen presenting cells (macrophages, dendritic cells and B cells). During recent years, genes encoding MHC class I and II, TCR and their co-receptors CD8 and CD4 have been cloned in several fish species and antibodies have been developed to study protein expression in morphological and functional contexts. However, mabs specific for TCR or CD3 have not been established yet. Therefore, using pan-T cell marker specific mabs, the activation and kinetics of T cell subpopulation should be investigated (chapter 2). Moreover, a flow cytometry method was established using different lineage marker specific mabs to measure different leukocyte populations and their involvement in immune mechanisms of trout using a single tube assay (chapter 3). The first line of defense against altered body cells or pathogens is provided by evolutionarily ancient macrophages and natural killer (NK) cells. These innate mechanisms are well developed in bony fish. Two types of NK cell homologues have been described in fish: non-specific cytotoxic cells and NK-like cells (Shen et al. 2002, Shen et al. 2003, Shen et al. 2004, Fischer et al. 2013). Functional assays for innate and adaptive lymphocyte responses have been developed in only a few fish species. However, there are no tools available until now in trout to follow these cells directly in the immune response. The molecular characteristics and the expression on leukocyte subpopulations of CD56 were therefore analyzed. Furthermore, a mab that is specific for a molecule expressed only in NK cells but with uncommon expression kinetics was established (chapter 4). Overall, the established tools and methods allow a more detailed characterization of cellular immune mechanisms against intracellular pathogens in rainbow trout.